Rates of glycaemic deterioration in a real-world population with type 2 diabetes
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
There is considerable variability in how diabetes progresses after diagnosis. Progression modelling has largely focused on ‘time to failure’ methods, yet determining a ‘coefficient of failure’ has many advantages. We derived a rate of glycaemic deterioration in type 2 diabetes, using a large real-world cohort, and aimed to investigate the clinical, biochemical, pharmacological and immunological variables associated with fast and slow rates of glycaemic deterioration. An observational cohort study was performed using the electronic medical records from participants in the Genetics of Diabetes Audit and Research in Tayside Study (GoDARTS). A model was derived based on an individual’s observed HbA 1c measures from the first eligible HbA 1c after the diagnosis of diabetes through to the study end (defined as insulin initiation, death, leaving the area or end of follow-up). Each HbA 1c measure was time-dependently adjusted for the effects of non-insulin glucose-lowering drugs, changes in BMI and corticosteroid use. GAD antibody (GADA) positivity was defined as GAD titres above the 97.5th centile of the population distribution. The mean (95% CI) glycaemic deterioration for type 2 diabetes and GADA-positive individuals was 1.4 (1.3, 1.4) and 2.8 (2.4, 3.3) mmol/mol HbA 1c per year, respectively. A younger age of diagnosis, lower HDL-cholesterol concentration, higher BMI and earlier calendar year of diabetes diagnosis were independently associated with higher rates of glycaemic deterioration in individuals with type 2 diabetes. The rate of deterioration in those diagnosed at over 70 years of age was very low, with 66% having a rate of deterioration of less than 1.1 mmol/mol HbA 1c per year, and only 1.5% progressing more rapidly than 4.4 mmol/mol HbA 1c per year. We have developed a novel approach for modelling the progression of diabetes in observational data across multiple drug combinations. This approach highlights how glycaemic deterioration in those diagnosed at over 70 years of age is minimal, supporting a stratified approach to diabetes management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779 · cited 3×
“The UK Prospective Diabetes Study (UKPDS) reported that the presence of positive GAD antibody (GADA) concentrations predicted an increased likelihood of requirement for insulin [3].”
InfluentialGlucocorticoids and Type 2 Diabetes: From Physiology to Pathology
Di Dalmazi, G., Pagotto, U., Pasquali, R., & Vicennati, V. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/525093 · Cited by 168 · cited 1×
“A widely recognised side effect of glucocorticoids is to temporarily raise HbA1c [15], and a significant proportion of individuals were prescribed glucocorticoids during the study period.”
Cited by
Sattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., & Gudbjörnsdottir, S. (2019) · Circulation · doi:10.1161/circulationaha.118.037885 · Cited by 555
Dennis, J. M., Shields, B. M., Henley, W. E., Jones, A. G., & Hattersley, A. T. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30087-7 · Cited by 462
A Global Perspective of Latent Autoimmune Diabetes in Adults
Mishra, R., Hodge, K. M., Cousminer, D. L., Leslie, R. D., & Grant, S. F. A. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.07.001 · Cited by 87
Sattar, N., Presslie, C., Rutter, M. K., & McGuire, D. K. (2024) · Diabetes Care · doi:10.2337/dci23-0041 · Cited by 70
Assessment of two glycated hemoglobin immunoassays
Guadalupe Vargas, M., Pazmiño Gomez, B. J., Vera Lorenti, F. E., Álvarez Condo, G. M., Rodas Neira, E. I., Veron, D., Fernández Veron, M., Cercado, A. G., Bahar, B., Tufro, A., et al. (2020) · Endocrinología, Diabetes y Nutrición · doi:10.1016/j.endinu.2019.09.011 · Cited by 13
Metadata
- Authors
- Donnelly, L. A., Zhou, K., Doney, A. S. F., Jennison, C., Franks, P. W., & Pearson, E. R.
- Venue
- Diabetologia
- Published
- 2017-12-19
- Volume
- 61
- Issue
- 3
- Pages
- 607-615
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2777318825
- Cited by
- 61
- References
- 4
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rates of glycaemic deterioration in a real-world population with type 2 diabetes. https://app.cochat.ai/papers/10.1007/s00125-017-4519-5
- The paper
- Donnelly, L. A., Zhou, K., Doney, A. S. F., Jennison, C., Franks, P. W., & Pearson, E. R. (2018). Rates of glycaemic deterioration in a real-world population with type 2 diabetes. Diabetologia. https://doi.org/10.1007/s00125-017-4519-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.